Leoligin, the major lignan from Edelweiss, inhibits intimal hyperplasia of venous bypass grafts

AIMS: Despite the lower patency of venous compared with arterial coronary artery bypass grafts, ∼50% of grafts used are saphenous vein conduits because of their easier accessibility. In a search for ways to increase venous graft patency, we applied the results of a previous pharmacological study scr...

पूर्ण विवरण

में बचाया:
ग्रंथसूची विवरण
मुख्य लेखकों: Reisinger, Ute, Schwaiger, Stefan, Zeller, Iris, Messner, Barbara, Stigler, Robert, Wiedemann, Dominik, Mayr, Tobias, Seger, Christoph, Schachner, Thomas, Dirsch, Verena M., Vollmar, Angelika M., Bonatti, Johannes O., Stuppner, Hermann, Laufer, Günther, Bernhard, David
स्वरूप: Artigo
भाषा:Inglês
प्रकाशित: Oxford University Press 2009
विषय:
Original Articles
ऑनलाइन पहुंच:https://ncbi.nlm.nih.gov/pmc/articles/PMC2682615/
https://ncbi.nlm.nih.gov/pubmed/19228707
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/cvr/cvp059
टैग : टैग जोड़ें
कोई टैग नहीं, इस रिकॉर्ड को टैग करने वाले पहले व्यक्ति बनें!

समान संसाधन